Imugene (ASX:IMU) report PD1-Vaxx generates high levels of antibodies

  • Home
  • Company News
  • Imugene (ASX:IMU) report PD1-Vaxx generates high levels of antibodies
28Jan

Imugene (ASX:IMU) report PD1-Vaxx generates high levels of antibodies

 

Immuno-therapy company Imugene (ASX:IMU) report that studies have shown their PD1-Vaxx cancer immunotherapy drug generates high levels of antibodies.

They will start trials with for patients with non-small cell lung cancer.

This the most common type of lung cancer, accounting for around 80 per cent of cases.

Imugene’s MD and CEO, Leslie Chong says the phase 1 trails in 2020 are a an important next step in bringing much needed new therapeutic option to cancer patients.

Shares in Imugene (ASX:IMU) are trading 2.9 per cent higher at $0.04.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

16Dec

Restaurant Brands (ASX:RBD) posts strong third quarter

16 Dec 2019 - Restaurant Brands’ (ASX:RBD) total sales for the third quarter of the financial year rose by 5.8 per cent to $192.0 million, compared to the year-earlier period.

Read More
07Jun

Stocks of the Hour: PYC Therapeutics, Caprice Resources, Walkabout Resources

07 Jun 2024 - A snapshot of the stocks on the move, featuring PYC Therapeutics (ASX:PYC), Caprice Resources (ASX:CRS) and Walkabout Resources (ASX:WKT).

Read More
29Nov

Westpac (ASX:WBC) appoints Acting Group Executive Enterprise Services

29 Nov 2019 - More shakeups at the board level for Westpac Banking Corporation (ASX:WBC) as it comes to terms with the AUSTRAC statement of claim.

Read More
11Jun

JB Hi-Fi (ASX:JBH) report strong sales growth in 2H20

11 Jun 2020 - JB Hi-Fi (ASX:JBH) and The Good Guys have seen strong sales growth in 2H20 as customers spend more time at home.

Read More
15Jun

Gentrack (ASX:GTK) executive chairman resigns

15 Jun 2020 - The executive chairman of essential service software provider Gentrack Group (ASX:GTK) John Clifford has resigned from the post for personal health reasons.

Read More
20Dec

Stocks of the Hour: Avecho Biotechnology, LBT Innovations, Meteoric Resources

20 Dec 2022 - A snapshot of the stocks on the move featuring Avecho Biotechnology (ASX:AVE), LBT Innovations (ASX:LBT) and Meteoric Resources (ASX:MEI).

Read More
10Aug

Adairs (ASX:ADH) profit increases 19% for year

10 Aug 2020 - Bedding company Adairs (ASX:ADH) reports a 19% lift in FY2020 net profit after tax of $35.3 million compared to a year ago.

Read More
08Mar

ALS (ASX:ALQ) set to acquire Investiga

08 Mar 2021 - Global inspection business ALS (ASX:ALQ) today announced the acquisition of Investiga, a pharmaceutical testing business in Brazil and the USA.

Read More
03Jun

Perseus Mining (ASX:PRU) to acquire Exore Resources

03 Jun 2020 - Perseus Mining (ASX:PRU) will acquire junior Exore Resources in a $64 million all scrip deal.

Read More
10May

Stocks of the Hour: Ioneer, Magnum Min & Expl, Asra Minerals, Evergreen Lithium

10 May 2023 - A snapshot of the stocks on the move featuring Ioneer (ASX:INR), Magnum Mining & Exploration (ASX:MGU), Asra Minerals (ASX:ASR) and Evergreen Lithium (ASX:EG1).

Read More